imipramine has been researched along with Cognition Disorders in 20 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Excerpt | Relevance | Reference |
---|---|---|
"Depression is a highly prevalent concomitant of dementia." | 2.40 | Depression and dementia: comorbidities, identification, and treatment. ( Meyers, BS, 1998) |
"Honokiol (10mg/kg) treated group depicted marked reduction in cognitive impairment and depressive-like behaviour." | 1.43 | Honokiol abrogates chronic restraint stress-induced cognitive impairment and depressive-like behaviour by blocking endoplasmic reticulum stress in the hippocampus of mice. ( Baruah, CC; Dwivedi, S; Gurjar, SS; Jangra, A; Kwatra, M; Lahkar, M; Sriram, CS; Sulakhiya, K, 2016) |
"Imipramine is a commonly used tricyclic antidepressant (TCA)." | 1.37 | Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice. ( Farahvar, A; Han, X; Huang, JH; Samadani, U; Smith, DH; Tong, J; Wang, E; Yang, J; Zhang, J, 2011) |
"The results showed that memory deficits were reversed with curcumin in a dose dependent manner, as were stress-induced increases in serum corticosterone levels." | 1.35 | Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress. ( Barish, PA; Li, G; Li, S; Lin, D; Ogle, WO; Pan, J; Shyamala, SG; Vernon, MM; Xu, Y, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (55.00) | 18.7374 |
1990's | 2 (10.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 5 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wagner, GJ | 1 |
Ngo, VK | 1 |
Nakasujja, N | 1 |
Akena, D | 1 |
Aunon, F | 1 |
Musisi, S | 1 |
Jangra, A | 1 |
Dwivedi, S | 1 |
Sriram, CS | 1 |
Gurjar, SS | 1 |
Kwatra, M | 1 |
Sulakhiya, K | 1 |
Baruah, CC | 1 |
Lahkar, M | 1 |
Xu, Y | 1 |
Lin, D | 1 |
Li, S | 1 |
Li, G | 1 |
Shyamala, SG | 1 |
Barish, PA | 1 |
Vernon, MM | 1 |
Pan, J | 1 |
Ogle, WO | 1 |
Han, X | 1 |
Tong, J | 1 |
Zhang, J | 1 |
Farahvar, A | 1 |
Wang, E | 1 |
Yang, J | 1 |
Samadani, U | 1 |
Smith, DH | 1 |
Huang, JH | 1 |
Hymel, KA | 1 |
Sufka, KJ | 1 |
Nardi, M | 1 |
Anwander, M | 1 |
Rüegger-Frey, B | 1 |
Bopp-Kistler, I | 1 |
Garcia-Toro, M | 1 |
Talavera, JA | 1 |
Gonzalez, E | 1 |
Tejada, P | 1 |
Blanco, C | 1 |
Gonzalez, A | 1 |
Saiz-Ruiz, J | 1 |
Graham, PM | 1 |
Potter, JM | 1 |
Paterson, J | 1 |
Stapert, WG | 1 |
Glass, RM | 2 |
Uhlenhuth, EH | 1 |
Hartel, FW | 1 |
Matuzas, W | 1 |
Fischman, MW | 1 |
Thompson, PJ | 1 |
Trimble, MR | 1 |
Busch, KT | 1 |
Schulz, H | 1 |
Marcos, T | 1 |
Salamero, M | 1 |
Gutiérrez, F | 1 |
Catalán, R | 1 |
Gasto, C | 1 |
Lázaro, L | 1 |
Meyers, BS | 1 |
Weinreb, H | 1 |
Gelder, MG | 1 |
Thomasová, E | 1 |
Mlcáková, K | 1 |
Kümpel, Q | 1 |
MacDonald, DJ | 1 |
Raskin, A | 1 |
Davies, RK | 1 |
Tucker, GJ | 1 |
Harrow, M | 1 |
Detre, TP | 1 |
1 review available for imipramine and Cognition Disorders
Article | Year |
---|---|
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cog | 1998 |
2 trials available for imipramine and Cognition Disorders
Article | Year |
---|---|
Cognitive dysfunction and imipramine in outpatient depressive.
Topics: Adult; Attention; Clinical Trials as Topic; Cognition Disorders; Depressive Disorder; Double-Blind M | 1981 |
Imipramine-reversible cognitive deficit in outpatient depressives [proceedings].
Topics: Adult; Clinical Trials as Topic; Cognition Disorders; Depression; Double-Blind Method; Humans; Imipr | 1978 |
17 other studies available for imipramine and Cognition Disorders
Article | Year |
---|---|
Impact of antidepressant therapy on cognitive aspects of work, condom use, and psychosocial well-being among HIV clients in Uganda.
Topics: Adult; Antidepressive Agents; Cognition Disorders; Condoms; Depressive Disorder, Major; Developing C | 2014 |
Honokiol abrogates chronic restraint stress-induced cognitive impairment and depressive-like behaviour by blocking endoplasmic reticulum stress in the hippocampus of mice.
Topics: Animals; Behavior, Animal; Biphenyl Compounds; Brain-Derived Neurotrophic Factor; Cognition Disorder | 2016 |
Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress.
Topics: Animals; Antidepressive Agents, Tricyclic; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cells | 2009 |
Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice.
Topics: Animals; Brain Injuries; Cognition Disorders; Disease Models, Animal; Hippocampus; Imipramine; Male; | 2011 |
Pharmacological reversal of cognitive bias in the chick anxiety-depression model.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Anxiety; Bias; Chickens; Clo | 2012 |
[There's not only Alzheimer's disease].
Topics: Accidental Falls; Aged; Alzheimer Disease; Antidepressive Agents; Cognition Disorders; Comorbidity; | 2012 |
Audioverbal cognitive dysfunction in depression. Factors involved.
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention; Cognition Dis | 2003 |
Combination monoamine oxidase inhibitor/tricyclic antidepressants interaction.
Topics: Adolescent; Anorexia Nervosa; Cognition Disorders; Confusion; Drug Interactions; Female; Fever; Huma | 1982 |
[The child who is suddenly confused and hallucinating].
Topics: Anthracenes; Child; Cognition Disorders; Confusion; Drug Synergism; Hallucinations; Humans; Imiprami | 1983 |
Non-MAOI antidepressant drugs and cognitive functions: a review.
Topics: Amitriptyline; Antidepressive Agents; Cognition; Cognition Disorders; Depressive Disorder; Dose-Resp | 1982 |
[The acute psychiatric emergency].
Topics: Acute Disease; Aged; Alcoholism; Amitriptyline; Brain Ischemia; Cognition Disorders; Consciousness D | 1981 |
Cognitive dysfunctions in recovered melancholic patients.
Topics: Adult; Aged; Attention; Cognition Disorders; Depressive Disorder; Female; Humans; Imipramine; Male; | 1994 |
Panic attacks: new approaches to an old problem.
Topics: Affective Symptoms; Cognition Disorders; Fear; Humans; Hyperventilation; Imipramine; Locus Coeruleus | 1986 |
Confusional states in elderly mental patients treated with antidepressants.
Topics: Aged; Amitriptyline; Cognition Disorders; Confusion; Depression; Drug Therapy, Combination; Female; | 1974 |
Psychotic reactions during organ transplantation.
Topics: Cognition Disorders; Depression; Erectile Dysfunction; Female; Humans; Imipramine; Kidney Transplant | 1972 |
Age-sex differences in response to antidepressant drugs.
Topics: Adjustment Disorders; Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Anxiety; Chlorpro | 1974 |
Confusional episodes and antidepressant medication.
Topics: Adolescent; Adult; Age Factors; Aged; Amitriptyline; Antidepressive Agents; Child; Cognition Disorde | 1971 |